News

Time course for blood pressure lowering of beta‐blockers with partial agonist activity
Plain language conclusions:Background
Autumn 2020 HTN newsletter now available!
Cochrane Hypertension publishes a quarterly newsletter with updates on our systematic reviews, training, and other editorial team activities and news. Subscribe to the Cochrane HTN newsletter.
Pitavastatin for lowering lipids
Implications for practice1. Pitavastatin causes a linear dose‐response reduction in the per cent change from control of blood LDL cholesterol, total cholesterol and blood triglycerides. There is no dose‐response relationship for HDL cholesterol which is increased by 4% on average for all doses. This effect on HDL is not different from the other studied statins.
Spring 2020 HTN newsletter now available!
Cochrane Hypertension publishes a quarterly newsletter with updates on our systematic reviews, training, and other editorial team activities and news. Subscribe to the Cochrane HTN newsletter.
Screening strategies for hypertension
Conclusions:
Withdrawal of antihypertensive drugs in older people
Plain language conclusions:
Introducing the Cochrane Circulation & Breathing Network
Introducing the Cochrane Circulation & Breathing NetworkWatch the video: https://buff.ly/2XlwLJE
Pharmacotherapy for hypertension in adults 60 years or older
Conclusions:
Winter 2020 HTN newsletter now available!
Cochrane Hypertension publishes a quarterly newsletter with updates on our systematic reviews, training, and other editorial team activities and news. Subscribe to the Cochrane HTN newsletter.Our latest newsletter (Winter 2020) is now available
Renin inhibitors v first‐line antihypertensive drugs for hypertension
First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension